Loading…
Disclosed for 93 months, Jan 2019 to Sep 2026.
quant Multi Cap Fund is an active equity fund in the Multi Cap category from quant Mutual Fund. In April 2020 it disclosed 22 stocks worth ₹9 Cr, up ₹1.4 Cr from Mar 2020. Its largest positions were Bharti Airtel Limited (9.7%), SBI Life Insurance Company Limited (8.9%), Bayer Cropscience Limited (7.1%); the ten largest together made up 61.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 25.4% of its equity. Cash and debt stood at 9.0%. Compared with Mar 2020 the fund entered 14 new stocks and exited 18.
Top-10 weight is higher than 100% of peers
Holds more stocks than 0% of peers
Holds more cash than 94% of peers
What these mean: concentration · cash
Every line the fund disclosed, with the change against Mar 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Bharti Airtel Limited | 9.73% | up 3.55 pts | ₹87 L | up ₹40 L | Added |
| Cash, TREPS & receivables | 9.01% | up 4.24 pts | ₹81 L | up ₹44 L | Added |
| SBI Life Insurance Company Limited | 8.89% | up 8.89 pts | ₹80 L | up ₹80 L | New |
| Bayer Cropscience Limited | 7.10% | up 7.10 pts | ₹64 L | up ₹64 L | New |
| Nippon Life India Asset Management Limited | 6.27% | down 1.19 pts | ₹56 L | down ₹1 L | Trimmed |
| Biocon Limited | 5.39% | up 5.39 pts | ₹48 L | up ₹48 L | New |
| Godrej Agrovet Limited | 5.03% | up 1.21 pts | ₹45 L | up ₹16 L | Added |
| Vinati Organics Limited | 4.86% | up 4.86 pts | ₹44 L | up ₹44 L | New |
| Sumitomo Chemical India Limited | 4.86% | up 4.86 pts | ₹44 L | up ₹44 L | New |
| Strides Pharma Science Limited | 4.71% | up 1.96 pts | ₹42 L | up ₹21 L | Added |
| Godrej Consumer Products Limited | 4.36% | up 1.18 pts | ₹39 L | up ₹15 L | Added |
| Zydus Lifesciences Limited | 4.12% | down 2.44 pts | ₹37 L | down ₹13 L | Trimmed |
| GlaxoSmithKline Pharmaceuticals Limited | 3.29% | up 0.89 pts | ₹29 L | up ₹11 L | Added |
| HDFC Bank Limited | 2.96% | up 2.96 pts | ₹27 L | up ₹27 L | New |
| AstraZeneca Pharma India Limited | 2.85% | up 2.85 pts | ₹26 L | up ₹26 L | New |
| Natco Pharma Limited | 2.65% | up 2.65 pts | ₹24 L | up ₹24 L | New |
| Dhanuka Agritech Limited | 2.61% | up 2.61 pts | ₹23 L | up ₹23 L | New |
| Rallis India Limited | 2.59% | up 2.59 pts | ₹23 L | up ₹23 L | New |
| BASF India Limited | 2.33% | up 2.33 pts | ₹21 L | up ₹21 L | New |
| Alembic Pharmaceuticals Limited | 2.12% | down 0.70 pts | ₹19 L | down ₹2 L | Trimmed |
| CLARIANT CHEMICALS (INDIA) LTD. | 1.54% | up 1.54 pts | ₹14 L | up ₹14 L | New |
| Torrent Pharmaceuticals Limited | 1.44% | up 1.44 pts | ₹13 L | up ₹13 L | New |
| Caplin Point Laboratories Limited | 1.29% | up 1.29 pts | ₹12 L | up ₹12 L | New |
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Mar 2020, the weight rose most in Fertilizers & Agrochemicals (+18.9 pts) and Insurance (+9.8 pts), and fell most in Diversified FMCG (−10.3 pts) and Beverages (−6.1 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Apr 2019 | Oct 2019 | Jan 2020 | Mar 2020 | Apr 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 7.7% | 1.5% | 20.0% | 24.2% | 25.4% |
| Fertilizers & Agrochemicals | — | — | — | — | 18.9% |
| Telecom - Services | — | 3.0% | — | 6.5% | 10.7% |
| Insurance | 6.3% | 28.6% | 14.1% | — | 9.8% |
| Chemicals & Petrochemicals | — | — | — | — | 7.9% |
| Capital Markets | — | 8.9% | 8.5% | 7.8% | 6.9% |
| Food Products | — | — | — | 8.2% | 5.5% |
| Pharmaceuticals | — | — | — | 2.9% | 5.2% |
| Personal Products | 3.7% | — | — | 5.8% | 4.8% |
| Banks | 10.6% | 13.5% | 17.2% | 5.3% | 3.3% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| Jun 2026 |
| ₹7,761 Cr |
| 47 |
| 3 |
| 4 |
| 5.8% |
| 10.0% |
| 289% |
| May 2026 | ₹7,664 Cr | 48 | 2 | 3 | 0.5% | 4.3% | 267% |
| Apr 2026 | ₹7,466 Cr | 49 | 1 | 3 | 0.2% | 4.1% | 271% |
| Mar 2026 | ₹6,574 Cr | 51 | 2 | 1 | 1.1% | 6.2% | 261% |
| Feb 2026 | ₹7,274 Cr | 50 | 6 | 3 | 6.6% | 12.0% | 258% |
| Jan 2026 | ₹7,456 Cr | 47 | 2 | 6 | 3.8% | 7.6% | 235% |
| Dec 2025 | ₹8,188 Cr | 51 | 3 | 3 | 0.4% | 4.4% | 214% |
| Nov 2025 | ₹8,804 Cr | 51 | 1 | 3 | 0.5% | 3.5% | 194% |
| Oct 2025 | ₹9,323 Cr | 53 | 4 | 3 | 2.1% | 4.8% | 179% |
| Sep 2025 | ₹9,240 Cr | 52 | 1 | 3 | 0.3% | 2.2% | 141% |
| Aug 2025 | ₹9,200 Cr | 54 | 2 | 7 | 3.4% | 5.9% | 147% |
| Jul 2025 | ₹9,632 Cr | 59 | 4 | 4 | 7.1% | 9.7% | 148% |
| Jun 2025 | ₹10,130 Cr | 59 | 4 | 3 | −1.7% | 0.8% | 156% |
| May 2025 | ₹9,927 Cr | 58 | 9 | 3 | −2.9% | 0.3% | 163% |
| Apr 2025 | ₹9,549 Cr | 52 | 3 | 3 | 2.1% | 5.9% | 164% |
| Mar 2025 | ₹9,389 Cr | 52 | 4 | 3 | 1.9% | 5.4% | 169% |
| Feb 2025 | ₹8,767 Cr | 51 | 1 | 6 | 5.5% | 7.2% | 168% |
| Jan 2025 | ₹9,863 Cr | 56 | 4 | 2 | 0.3% | 3.4% | 179% |
| Dec 2024 | ₹10,285 Cr | 54 | 3 | 2 | −0.1% | 2.3% | 186% |
| Nov 2024 | ₹10,614 Cr | 53 | 7 | 1 | −0.8% | 1.5% | 206% |
| Oct 2024 | ₹10,531 Cr | 47 | 2 | 0 | 6.0% | 7.0% | 232% |
For any of the 69 earlier months, choose it in “Portfolio as of” at the top of the page.